Carbon Biosciences

About:

Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.

Top Investors: Longwood Fund, UTokyo Innovation Platform, Astellas Venture Management, Agent Capital, Solasta Ventures

Description:

Carbon Biosciences develops genetic medicines for the treatment of devastating diseases. They develop their vector using industrial-scale viral production platforms and can be used to deliver a wide-range of therapeutic modalities.

Total Funding Amount:

$38M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2021-01-01

Founders:

Joel Schneider, Robert Kotin

Number of Employees:

11-50

Last Funding Date:

2022-06-21

IPO Status:

Private

Industries: